Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen

International Immunology

Volumn 19, Issue 3, 2007, Pages 331-336

  Dong, Lingli ^a,b   Masaki, Yasufumi ^a   Takegami, Tsutomu ^a   Kawanami, Takafumi ^a   Itoh, Kunihiko ^c   Jin, Zhe Xiong ^a   Huang, Cheng Ri ^a   Tong, Xiao Peng ^a   Fukushima, Toshihiro ^a   Tanaka, Masao ^a   Sawaki, Toshioki ^a   Sakai, Tomoyuki ^a   Sugai, Susumu ^a   Okazaki, Toshiro ^d   Hirose, Yuko ^a   Umehara, Hisanori ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DAUDI CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SJOEGREN SYNDROME; TUMOR IMMUNITY; VIRUS CARCINOGENESIS; VIRUS IMMUNITY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CAPSID PROTEINS; CELL LINE; CLONING, MOLECULAR; COMBINATORIAL CHEMISTRY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; SEQUENCE ANALYSIS, PROTEIN; SJOGREN'S SYNDROME;

EID: 33847375988     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl150     Document Type: Article

References (33)

1. Thompson, M. P. and Kurzrock, R. 2004. Epstein-Barr virus and cancer. Clin. Cancer Res. 10:803.
2. Williams, H. and Crawford, D. H. 2006. Epstein-Barr virus: The impact of scientific advances on clinical practice. Blood 107:862.
3. Sugimoto, M., Tahara, H., Ide, T. and Furuichi, Y. 2004. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64:3361.
4. Drouet, E., Brousset, P., Fares, F. et al. 1999. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J. Med. Virol. 57:383.
5. Hess, R. D. 2004. Routine Epstein-Barr virus diagnostics from the laboratory perspective: Still challenging after 35 years. J. Clin. Microbiol. 42:3381.
6. Gross, A. J., Hochberg, D., Rand, W. M. and Thorley-Lawson, D. A. 2005. EBV and systemic lupus erythematosus: A new perspective. J. Immunol. 174:6599.
7. Chen, C. J., Lin, K. H., Lin, S. C. et al. 2005. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: Case control studies. J. Rheumatol. 32:44.
8. Paschke, M. 2006. Phage display systems and their applications. Appl. Microbiol. Biotechnol. 70:2.
9. Barbas, C. F. III 1993. Recent advances in phage display. Curr. Opin. Biotechnol. 4:526.
10. Zhang, M. Y., Xiao, X., Sidorov, I. A. et al. 2004. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J. Virol. 78:9233.
11. Higo-Moriguchi, K., Akahori, Y., Iba, Y., Kurosawa, Y. and Taniguchi, K. 2004. Isolation of human monoclonal antibodies that neutralize human rotavirus. J. Virol. 78:3325.
12. Flego, M., Di Bonito, P., Ascione, A. et al. 2005. Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach. BMC Infect. Dis. 5:73.
13. Ditzel, H. J., Masaki, Y., Nielsen, H., Farnaes, L. and Burton, D. R. 2000. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome. Proc. Natl Acad. Sci. USA 97:9234.
14. Itoh, K., Nakagomi, O., Suzuki, K., Inoue, K., Tada, H. and Suzuki, T. 1999. Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries. J. Biochem. (Tokyo) 125:123.
15. Ditzel, H. J., Binley, J. M., Moore, J. P. et al. 1995. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J. Immunol. 154:893.
16. Miyaji, M., Jin, Z. X., Yamaoka, S. et al. 2005. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J. Exp. Med. 202:249.
17. Liu, M. Y., Huang, Y. T., Sheen, T. S., Chen, J. Y. and Tsai, C. H. 2004. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma. J. Med. Virol. 73:574.
18. Hirose, Y., Masaki, Y., Yoshioka, R. and Takiguchi, T. 1997. Aggressive natural killer cell lymphoproliferative disorder associated with Epstein-Barr viral RNA. Am. J. Hematol. 54:314.
19. Hirose, Y., Masaki, Y., Sawaki, T. et al. 2006. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan. Eur. J. Haematol. 76:109.
20. Johannsen, E., Luftig, M., Chase, M. R. et al. 2004. Proteins of purified Epstein-Barr virus. Proc. Natl Acad. Sci. USA 101:16286.
21. van Grunsven, W. M., van Heerde, E. C., de Haard, H. J., Spaan, W. J. and Middeldorp, J. M. 1993. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J. Virol. 67:3908.
22. Serio, T. R., Angeloni, A., Kolman, J. L. et al. 1996. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21). J. Virol. 70:8047.
23. Besson, C., Amiel, C., Le-Pendeven, C. et al. 2006. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J. Clin. Microbiol. 44:47.
24. Stevens, S. J., Blank, B. S., Smits, P. H., Meenhorst, P. L. and Middeldorp, J. M. 2002. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: Correlation with antiretroviral therapy and quantitative EBV serology. AIDS 16:993.
25. Rogers, B. B., Conlin, C., Timmons, C. F., Dawson, D. B., Krisher, K. and Andrews, W. S. 1997. Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients. Pediatr. Pathol. Lab. Med. 17:391.
26. Jarrett, R. F., Stark, G. L., White, J. et al. 2005. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 106:2444.
27. Keegan, T. H., Glaser, S. L., Clarke, C. A. et al. 2005. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study. J. Clin. Oncol. 23:7604.
28. Yang, X., Goldstein, A. M., Chen, C. J. et al. 2006. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan. Int. J. Cancer 118:780.
29. Bugli, F., Bastidas, R., Burton, D. R., Williamson, R. A., Clementi, M. and Burioni, R. 2001. Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen. Hum. Immunol. 62:362.
30. Liao, G., Huang, J., Fixman, E. D. and Hayward, S. D. 2005. The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor. J. Virol. 79:245.
31. Cattaneo, A. and Biocca, S. 1999. The selection of intracellular antibodies. Trends Biotechnol. 17:115.
32. Weiner, L. M. 2006. Fully human therapeutic monoclonal anti-bodies. J. Immunother. 29:1.
33. Sharon, J., Liebman, M. A. and Williams, B. R. 2005. Recombinant polyclonal antibodies for cancer therapy. J. Cell. Biochem. 96:305.